[Publication] Tseng AH, Yang JC, Chen CH, Chen CH, Hsu SL, Lee MH, Lee HC*and Su LJ*. Anin vivoMolecular Response Analysis of Colorectal Cancer Treated with Traditional Chinese MedicineAstragalus membranaceusExtract. Oncology Reports. 2016; 35 (2): 659-668.*These authors contributed equally.
[Publication] Liu CC, Su LJ, Tsai WY, Sun HL, Lee HC and Wong CS. Hylan G-F 20 attenuates posttraumatic osteoarthritis progression: association with upregulated expression of the circardian gene NPAS2. Life Sciences. 2015; 141: 20-24.
[Publication] Chen CH, Chang AY, Li SH, Tsai HT, Shiu LY, Su LJ, Wang WL, Chiu TJ, Luo SD, Huang TL and Chien CY. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer. Molecular Cancer. 2015;14(1):83.
[Publication] Huang HL, WuCY, Su LJ, Huang YJ, Charoenkwan P, Chen WL, Lee HC, Chu CCW and Ho SY. Discovery of prognostic biomarkers for predicting lung cancer metastasis using microarray and survival data. BMC Bioinformatics. 2015; 16: 54.
[Publication] Chen CH, Hsu CL, Huang SH, Chen SY,HungYL, Chen HR, Wu YC, Su LJ* and Lee HC*.
Method Designed to Respect Molecular Heterogeneity Can Profoundly Correct Present Data Interpretations for Genome-Wide Expression Analysis.
[Publication] Wei TY*, Hsia JY*, Chiu SC*, Su LJ*, Juan CC*, Lee YC*, Chen JM*, Chou HY, Huang JY, Huang HM, Yu CT. Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis. Cellular Signalling. 2014; 26(12): 2940-2950. *These authors contributed equally.
[Publication] Chian.g KC, Yeh CN, Lin KJ, Su LJ, Yen TC, Pang JHS, Kittaka A, Sun CC, Chen MF,Jan YY, Chen TC, Juang HH and Yeh TS. Chemopreventive and Chemotherapeutic Effect of Dietary Supplementation of Vitamin D on Cholangiocarcinoma in a Chemical-Induced Animal Model. Oncotarget. 2014; 5 (11): 3849-61.
[Publication] Chien CY, Tsai1 HT, Su LJ, Chuang HC, Shiu LY, Huang CC, Fang FM, Yu CC, Su HT, and Chen CH. Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior. Oncotarget. 2014; 5(8): 2243-2262.